Síndrome de Cushing

  • Johnayro Gutiérrez Restrepo Universidad de Antioquia
  • Guillermo Latorre Sierra Universidad de Antioquia
  • Germán Campuzano Maya Laboratorio Clínico Hematológico, Universidad de Antioquia
Palabras clave: síndrome de Cushing, cortisol, hipercortisolemia, pruebas dinámicas, laboratorio, diagnóstico.

Resumen

El síndrome de Cushing se presenta como resultado de la exposición a altas concentraciones de cortisol. A pesar de que se considera una enfermedad rara, se caracteriza por una alta morbilidad y mortalidad, si no se trata; por lo tanto, el diagnóstico temprano y la identificación de su causa son indispensables para un manejo adecuado del paciente. El diagnóstico de síndrome de Cushing es un desafío para el endocrinólogo, quien debe conocer la utilidad y la correcta interpretación de las pruebas diagnósticas. El diagnóstico incluye dos pasos: primero, confirmar el estado de hipercortisolemia con la ayuda de varias pruebas de tamización; y segundo, identificar la causa de la hipercortisolemia. Los resultados de laboratorio deben ser interpretados en forma conjunta con las manifestaciones clínicas y con los hallazgos radiológicos.

Descargas

La descarga de datos todavía no está disponible.

Biografía del autor/a

Johnayro Gutiérrez Restrepo, Universidad de Antioquia

Médico Internista, Residente de segundo año de Endocrinología Clínica y Metabolismo, Universidad de Antioquia, Medellín, Colombia.

Guillermo Latorre Sierra, Universidad de Antioquia

Médico especialista en Medicina Interna y Endocrinología. Docente Endocrinología Clínica y Metabolismo, Jefe de la Sección de Endocrinología y Metabolismo. Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.

Germán Campuzano Maya, Laboratorio Clínico Hematológico, Universidad de Antioquia

Médico especialista en Hematología y Patología Clínica. Docente, Ad Honorem, Facultad de Medicina, Universidad de Antioquia.MédicoDirector,LaboratorioClínicoHematológico.Medellín,Colombia.

Referencias bibliográficas

Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 1932; 50.

Pivonello R, De Martino MC, De Leo M, Lom- bardi G, Colao A. Cushing's syndrome. Endocrinol Metab Clin North Am 2008; 37: 135-149, ix. https://doi.org/10.1016/j.ecl.2007.10.010

Orth DN. Cushing's syndrome. N Engl J Med 1995; 332: 791-803. https://doi.org/10.1056/NEJM199503233321207

Newell-Price J, Bertagna X, Grossman AB, Nie- man LK. Cushing's syndrome. Lancet 2006; 367: 1605-1617. https://doi.org/10.1016/S0140-6736(06)68699-6

Lahera Vargas M, da Costa CV. Prevalence, etiology and clinical findings of Cushing's syndrome. Endocrinol Nutr 2009; 56: 32-39. https://doi.org/10.1016/S1575-0922(09)70191-3

Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, et al. Incidence and late prognosis of Cushing's syndrome: a population-based study. J Clin Endocrinol Metab 2001; 86: 117-123. https://doi.org/10.1210/jc.86.1.117

Hutter AM, Jr., Kayhoe DE. Adrenal cortical carcinoma. Clinical features of 138 patients. Am J Med 1966; 41: 572-580. https://doi.org/10.1016/0002-9343(66)90219-1

Boscaro M, Arnaldi G. Approach to the patient with possible Cushing's syndrome. J Clin Endocrinol Metab 2009; 94: 3121-3131. https://doi.org/10.1210/jc.2009-0612

Wajchenberg BL, Bosco A, Marone MM, Levin S, Rocha M, Lerario AC, et al. Estimation of body fat and lean tissue distribution by dual energy X-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing's disease. J Clin Endocrinol Metab 1995; 80: 2791-2794. https://doi.org/10.1210/jcem.80.9.7673425

Koch CA, Doppman JL, Watson JC, Patronas NJ, Nieman LK. Spinal epidural lipomatosis in a patient with the ectopic corticotropin syndrome. N Engl J Med 1999; 341: 1399-1400. https://doi.org/10.1056/NEJM199910283411814

Mountjoy KG. The human melanocyte stimulating hormone receptor has evolved to become "super- sensitive" to melanocortin peptides. Mol Cell En- docrinol 1994; 102: R7-11. https://doi.org/10.1016/0303-7207(94)90113-9

Adler RA, Rosen CJ. Glucocorticoids and osteoporosis. Endocrinol Metab Clin North Am 1994; 23: 641-654. https://doi.org/10.1016/S0889-8529(18)30090-2

Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990; 112: 352-364. https://doi.org/10.7326/0003-4819-112-5-352

Tauchmanova L, Pivonello R, Di Somma C, Rossi R, De Martino MC, Camera L, et al. Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status. J Clin Endocrinol Metab 2006; 91: 1779-1784. https://doi.org/10.1210/jc.2005-0582

Teves DA. Clinical approach of cushing syndrome resulting from ACTH-producing metastatic neuroendocrine tumor. The Endocrinologist 2005; 15: 401- 404. https://doi.org/10.1097/01.ten.0000188475.05398.09

Terzolo M, Allasino B, Bosio S, Brusa E, Daffara F, Ventura M, et al. Hyperhomocysteinemia in patients with Cushing's syndrome. J Clin Endocrinol Metab 2004; 89: 3745-3751. https://doi.org/10.1210/jc.2004-0079

Newell-Price J, Grossman A. Diagnosis and management of Cushing's syndrome. Lancet 1999; 353: 2087-2088. https://doi.org/10.1016/S0140-6736(99)99091-8

Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93: 1526-1540. https://doi.org/10.1210/jc.2008-0125

Kola B, Grossman AB. Dynamic testing in Cushing's syndrome. Pituitary 2008; 11: 155- 162. https://doi.org/10.1007/s11102-007-0079-x

Santos S, Santos E, Gaztambide S, Salvador J. [Diagnosis and differential diagnosis of Cushing's syndrome]. Endocrinol Nutr 2009; 56: 71-84. https://doi.org/10.1016/S1575-0922(09)70555-8

Elamin MB, Murad MH, Mullan R, Erickson D, Harris K, Nadeem S, et al. Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab 2008; 93: 1553-1562. https://doi.org/10.1210/jc.2008-0139

Stewart PM. Classification and pathophysiology of Cushing's syndrome. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, eds. Kronenberg: Williams Textbook of Endocrinology, 11th ed. Philadelphia; WB Saunders. 2008.

Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 2003; 88: 5593-5602. https://doi.org/10.1210/jc.2003-030871

Nieman LK, Ilias I. Evaluation and treatment of Cushing's syndrome. Am J Med 2005; 118: 1340- 1346. https://doi.org/10.1016/j.amjmed.2005.01.059

Castro M, Moreira AC. Screening and diagnosis of Cushing's syndrome. Arq Bras Endocrinol Metabol 2007; 51: 1191-1198. https://doi.org/10.1590/S0004-27302007000800004

Makras P, Toloumis G, Papadogias D, Kaltsas GA, Besser M. The diagnosis and differential diagnosis of endogenous Cushing's syndrome. Hormones (Athens) 2006; 5: 231-250. https://doi.org/10.14310/horm.2002.11189

Cizza G, Nieman LK, Doppman JL, Passaro MD, Czerwiec FS, Chrousos GP, et al. Factitious Cus- hing syndrome. J Clin Endocrinol Metab 1996; 81: 3573-3577.

https://doi.org/10.1210/jcem.81.10.8855803

Wood PJ, Barth JH, Freedman DB, Perry L, Sheri- dan B. Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome- -recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 1997; 34 ( Pt 3): 222-229. https://doi.org/10.1177/000456329703400302

Newell-Price J, Trainer P, Perry L, Wass J, Grossman A, Besser M. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf); 43: 545-550. https://doi.org/10.1111/j.1365-2265.1995.tb02918.x

Findling JW, Raff H. Screening and diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am 2005; 34: 385-402, ix-x. https://doi.org/10.1016/j.ecl.2005.02.001

Reimondo G, Allasino B, Bovio S, Paccotti P, Angeli A, Terzolo M. Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome. Eur J Endocrinol 2005; 153: 803-809. https://doi.org/10.1530/eje.1.02042

Raff H, Raff JL, Findling JW. Late-night salivary cortisol as a screening test for Cushing's syndrome. J Clin Endocrinol Metab 1998; 83: 2681-2686. https://doi.org/10.1210/jc.83.8.2681

Erickson D, Natt N, Nippoldt T, Young WF, Jr., Carpenter PC, Petterson T, et al. Dexamethasone- suppressed corticotropin-releasing hormone stimulation test for diagnosis of mild hypercortisolism. J Clin Endocrinol Metab 2007; 92: 2972-2976. https://doi.org/10.1210/jc.2006-2662

Morris DG, Grossman AB. Dynamic tests in the diagnosis and differential diagnosis of Cushing's syndrome. J Endocrinol Invest 2003; 26: 64-73.

Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 1998; 19: 647-672. https://doi.org/10.1210/edrv.19.5.0346

Dichek HL, Nieman LK, Oldfield EH, Pass HI, Malley JD, Cutler GB, Jr. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 1994; 78: 418-422.

Yanovski JA, Cutler GB, Jr., Chrousos GP, Nieman LK. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. JAMA 1993; 269: 2232-2238. https://doi.org/10.1001/jama.1993.03500170062035

Aron DC, Raff H, Findling JW. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin- dependent Cushing's syndrome. J Clin Endocrinol Metab 1997; 82: 1780-1785. https://doi.org/10.1210/jcem.82.6.3991

Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, et al. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 2003; 88: 5299-5306. https://doi.org/10.1210/jc.2003-030510

Newell-Price J, Morris DG, Drake WM, Korbonits M, Monson JP, Besser GM, et al. Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome. J Clin Endocrinol Metab 2002; 87: 1640-1645. https://doi.org/10.1210/jcem.87.4.8357

Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic- Pituitary-Adrenal Axis. J Clin Endocrinol Metab 1999; 84: 440-448. https://doi.org/10.1210/jc.84.2.440

Raff H, Findling JW. A physiologic approach to diagnosis of the Cushing syndrome. Ann Intern Med 2003; 138: 980-991. https://doi.org/10.7326/0003-4819-138-12-200306170-00010

Korbonits M, Kaltsas G, Perry LA, Putignano P, Grossman AB, Besser GM, et al. The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin. J Clin Endocrinol Metab 1999; 84: 2489-2495. https://doi.org/10.1210/jcem.84.7.5811

Lindsay JR, Nieman LK. Differential diagnosis and imaging in Cushing's syndrome. Endocrinol Metab Clin North Am 2005; 34: 403-421, x. https://doi.org/10.1016/j.ecl.2005.01.009

Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 1994; 120: 817-820. https://doi.org/10.7326/0003-4819-120-10-199405150-00001

Choyke PL. Commentary on "computed tomography in the diagnosis of adrenal disease" and "non- functioning adrenal masses: incidental discovery on computed tomography". AJR Am J Roentgenol 2009; 192: 568-570. https://doi.org/10.2214/AJR.08.1718

Honigschnabl S, Gallo S, Niederle B, Prager G, Kaserer K, Lechner G, et al. How accurate is MR imaging in characterisation of adrenal masses: up- date of a long-term study. Eur J Radiol 2002; 41: 113-122. https://doi.org/10.1016/S0720-048X(01)00443-0

Mansmann G, Lau J, Balk E, Rothberg M, Mi- yachi Y, Bornstein SR. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 2004; 25: 309-340. https://doi.org/10.1210/er.2002-0031

Sohaib SA, Rockall AG, Reznek RH. Imaging functional adrenal disorders. Best Pract Res Clin Endocrinol Metab 2005; 19: 293-310. https://doi.org/10.1016/j.beem.2004.10.001

Kurtaran A, Traub T, Shapiro B. Scintigraphic imaging of the adrenal glands. Eur J Radiol 2002; 41: 123-130. https://doi.org/10.1016/S0720-048X(01)00442-9

Avram AM, Fig LM, Gross MD. Adrenal gland scintigraphy. Semin Nucl Med 2006; 36: 212- 227. https://doi.org/10.1053/j.semnuclmed.2006.03.004

Gross MD, Avram A, Fig LM, Rubello D. Contemporary adrenal scintigraphy. Eur J Nucl Med Mol Imaging 2007; 34: 547-557. https://doi.org/10.1007/s00259-006-0265-5

Kaltsas GA, Giannulis MG, Newell-Price JD, Dacie JE, Thakkar C, Afshar F, et al. A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 1999; 84: 487-492. https://doi.org/10.1210/jcem.84.2.5437

Colao A, Faggiano A, Pivonello R, Pecori Giraldi F, Cavagnini F, Lombardi G. Inferior petrosal sinus sampling in the differential diagnosis of Cushing's syndrome: results of an Italian multicenter study. Eur J Endocrinol 2001; 144: 499-507. https://doi.org/10.1530/eje.0.1440499

Utz A, Biller BM. The role of bilateral inferior petrosal sinus sampling in the diagnosis of Cushing's syndrome. Arq Bras Endocrinol Metabol 2007; 51: 1329-1338. https://doi.org/10.1590/S0004-27302007000800019

Ilias I, Chang R, Pacak K, Oldfield EH, Wesley R, Doppman J, et al. Jugular venous sampling: an alternative to petrosal sinus sampling for the diagnostic evaluation of adrenocorticotropic hormone- dependent Cushing's syndrome. J Clin Endocrinol Metab 2004; 89: 3795-3800.

https://doi.org/10.1210/jc.2003-032014

Cómo citar
1.
Gutiérrez Restrepo J, Latorre Sierra G, Campuzano Maya G. Síndrome de Cushing. Med. Lab. [Internet]. 1 de septiembre de 2009 [citado 26 de septiembre de 2021];15(9-10):411-30. Disponible en: https://medicinaylaboratorio.com/index.php/myl/article/view/428
Publicado
2009-09-01
Sección
La Clínica y el Laboratorio

Más sobre este tema

Artículos más leídos del mismo autor/a

1 2 3 4 5 > >>